Cargando…
Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling
Background and objectives: Cancer stem cells (CSCs) are obstacles to cancer therapy due to their therapeutic resistance, ability to initiate neoplasia, and roles in tumor relapse and metastasis. Efforts have been made to cure CSCs, such as the use of differentiation therapy, which induces cancer ste...
Autores principales: | Chu, Inn-Ray, Pan, Rong-Long, Yang, Chung-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699282/ https://www.ncbi.nlm.nih.gov/pubmed/33227992 http://dx.doi.org/10.3390/medicina56110625 |
Ejemplares similares
-
IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
por: Chen, Miao-Fen, et al.
Publicado: (2013) -
URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription
por: Fan, J-L, et al.
Publicado: (2014) -
Correction: IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer
por: Chen, Miao-Fen, et al.
Publicado: (2016) -
Induction of neural differentiation in rat C6 glioma cells with taxol
por: Chao, Chuan‐Chuan, et al.
Publicado: (2015) -
NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma
por: Jiang, Yang, et al.
Publicado: (2017)